venlafaxine hydrochloride has been researched along with Depression in 253 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.40) | 18.7374 |
| 1990's | 17 (6.72) | 18.2507 |
| 2000's | 60 (23.72) | 29.6817 |
| 2010's | 136 (53.75) | 24.3611 |
| 2020's | 39 (15.42) | 2.80 |
| Authors | Studies |
|---|---|
| Gruca, P; Lason, M; Litwa, E; Papp, M; Solecki, W; Willner, P | 1 |
| Carmody, T; Chin-Fatt, C; Czysz, AH; Li, Q; Mason, BL; Minhajuddin, A; Trivedi, MH | 1 |
| Bučková, K; Finnegan, EM; Fureix, C; Mendl, MT; Paul, ES; Trevarthen, AC | 1 |
| Cao, L; Fang, L; Wang, S; Yao, K | 1 |
| Butler, D; Coupland, C; Hippisley-Cox, J; Hollis, C; Jack, RH; Joseph, RM; Knaggs, RD; Morriss, R | 1 |
| Altmann, HM; Blumberger, DM; Gebara, MA; Karp, JF; Kazan, J; Lenze, EJ; Mulsant, BH; Reynolds, CF; Stahl, ST | 1 |
| Breitinger, S; Frye, MA; Gardea-Resendez, M; Gerberi, DJ; Nuñez, NA; Park, JH; Singh, B; Veldic, M | 1 |
| Oda, Y; Sato, A; Shimizu, T; Shimoda, K; Shinozaki, M; Suzuki, Y; Yang, M; Yasui-Furukori, N | 1 |
| Han, YS; Jiang, HX; Li, CY; Li, ZR; Liu, DG; Wang, YH; Xie, S; Zou, MS | 1 |
| Balbuena, L; Lodhi, RJ; Peters, EM | 1 |
| Finn, DP; Joshi, A; McClean, PL; Todd, S; Wong-Lin, K | 1 |
| Gruca, P; Lason, M; Litwa, E; Papp, M; Willner, P | 1 |
| Blanchin, M; Brunelin, J; Bulteau, S; Pere, M; Poulet, E; Sauvaget, A; Sébille, V | 1 |
| Huang, F; Shen, W; Shi, H; Tao, Y; Wu, H; Wu, X; Zheng, F; Zhou, H | 1 |
| Chen, M; Fan, J; Guo, C; Liu, W; Liu, Y; Lu, H; Xu, J; Yang, J; Zhang, H | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
| Audano, M; Brivio, P; Calabrese, F; Fumagalli, F; Gallo, MT; Gruca, P; Lason, M; Litwa, E; Miceli, E; Mitro, N; Papp, M | 1 |
| Keidan, L; Pick, CG; Schreiber, S | 1 |
| Bhatele, P; Chand Sarangi, S; Dwivedi, R; Elavarasi, A; Kalaivani, M; Kumar Singh, R; Prarthana Chandra, P; Sagar, R; Tripathi, M; Vibha, D | 1 |
| Koriem, KMM; Tharwat, HAK | 1 |
| Chen, C; Chen, F; Chen, P; Guan, YX; Jiang, B; Shen, JH; Wu, ZH; Xu, H | 1 |
| Chen, L; Gan, L; Huang, C; Liao, Z; Liu, C; Su, T; Yuan, M; Zhang, L | 1 |
| Bérard, A; Dandjinou, M; Sheehy, O | 1 |
| Jung, C; Karp, JF; Peciña, M; Stahl, ST; Weiner, DK | 1 |
| Alvarez Silva, A; Fernández-Guasti, A | 1 |
| Lenze, EJ; Miller, JP; Mulsant, BH; Nicol, G; Reynolds, CF; Saade, YM; Wetherell, JL; Yingling, M | 1 |
| Baszko, A; Elikowski, W; Fertała, N; Ganowicz-Kaatz, T; Małek-Elikowska, M; Słomczyński, M; Zawodna, M | 1 |
| Eggleston, K; Porter, RJ | 1 |
| Hantson, P; Haufroid, V; Volon, B; Willemart, T | 1 |
| Blumberger, DM; Fiori, LM; Foster, JA; Islam, F; Karp, JF; Kennedy, JL; Kennedy, SH; Lenze, EJ; Maciukiewicz, M; Marshe, VS; Müller, DJ; Mulsant, BH; Reynolds, CF; Turecki, G; Yang, J; Yerko, V | 1 |
| Baba, H; Inada, K; Kato, M; Katsuki, A; Kikuchi, T; Kishida, I; Sakurai, H; Sugawara Kikuchi, Y; Suzuki, T; Uchida, H; Watanabe, K; Yasui-Furukori, N | 1 |
| Bates, DW; Buckeridge, DL; Dixon, WG; Girard, N; Haas, JS; Habib, B; Iqbal, U; Li, J; Sheppard, T; Tamblyn, R | 1 |
| Brink, CB; Harvey, BH; Steyn, SF | 1 |
| Baumgartner, M; Kuzin, M; Nolan, D; Paulzen, M; Scharrer, I; Schoretsanitis, G; Xepapadakos, F | 1 |
| Husain, MM; Kellner, CH; Lisanby, SH; McCall, WV; McClintock, SM; Mueller, M; Petrides, G; Speed, MS; Østergaard, SD | 1 |
| Bowman, MA; Daws, LC; Horton, RE; Koek, W; Mitchell, NC; Owens, WA | 1 |
| Chen, TT; Gao, TT; Guan, W; Jiang, B; Liu, L; Wang, JL; Wang, Y; Wang, YJ; Zhang, Y; Zhao, J | 1 |
| Birkenhäger, TK; Breteler, LMT; Janzing, JGE; Nolen, WA; van den Broek, WW; Verkes, RJ | 1 |
| Asami, Y; Boucher, M; Kato, M; Pappadopulos, E; Prieto, R; Wajsbrot, DB; Wang, X | 1 |
| Ait Chait, Y; Hammami, R; Mottawea, W; Tompkins, TA | 1 |
| Gavrilova, SI; Safarova, TP | 1 |
| Hayashi, Y; Inoue, Y; Kato, K; Komahashi-Sasaki, H; Sasaki, T; Shimoda, K; Shinozaki, M; Sugawara, N; Tsuchimine, S; Watanabe, T; Yasui-Furukori, N | 1 |
| Becker, T; Breilmann, J; Kösters, M; Reuter, B; Schneider, C | 1 |
| Garmendia, L; Gómez-Lazaro, E; Goñi-Balentziaga, O; Labaka, A; Pérez-Tejada, J; Vegas, O | 1 |
| Budziszewska, B; Detka, J; Głombik, K | 1 |
| Blumberger, DM; Bonner, AJ; Butters, MA; Chen, R; Daskalakis, ZJ; Downar, J; Karp, JF; Lenze, EJ; Lissemore, JI; Mulsant, BH; Rajji, TK; Reynolds, CF; Zomorrodi, R | 1 |
| Salanio, DM; Stanton, JED; Taylor, R; Wild, EJ | 1 |
| Bai, S; Chen, J; Chen, Z; Gui, S; Han, Y; Hu, Q; Huang, H; Liang, Z; Liu, Z; Shen, P; Wang, H; Wang, W; Xie, P; Xie, X; Zeng, L; Zhang, X | 1 |
| Khanam, R; Thomas, J; Vohora, D | 3 |
| Chen, CY; Ho, PS; Huang, CC; Huang, SY; Kuo, SC; Liang, CS; Lu, RB; Shyu, JF; Yeh, YW; Yen, CH | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Krishnamra, N; Lapmanee, S; Teerapornpuntakit, J | 1 |
| Dmitrzak-Weglarz, M; Kapelski, P; Narozna, B; Pawlak, J; Rajewska-Rager, A; Skibinska, M; Szczepankiewicz, A; Twarowska-Hauser, J | 1 |
| Blumberger, DM; Dixon, D; Karp, JF; Lenze, EJ; Mulsant, BH; Mulvahill, JS; Nicol, GE; Reynolds, CF | 1 |
| Kus, K; Nowakowska, E; Ratajczak, P; Skurzyńska, M | 1 |
| Binder, EB; Carrillo-Roa, T; Craighead, WE; Debattista, C; Dunlop, BW; Goldstein-Piekarski, AN; Mayberg, HS; Nemeroff, CB; O'Connell, CP; Schatzberg, AF; Williams, LM | 1 |
| Dronamraju, N; Greer, TL; Jha, MK; Minhajuddin, A; Trivedi, MH; Wakhlu, S | 1 |
| Belovicová, K; Bogi, E; Dubovicky, M; Garafová, A; Jezova, D; Koprdova, R; Mach, M; Ujhazy, E; Zilava, L | 1 |
| Gao, X; Karp, JF; Morse, JQ; Reynolds, CF; Rollman, BL; Wahed, AS; Weiner, DK | 1 |
| Cardozo, T; Felsovalyi, K; Grunebaum, MF; Kim, EJ; Shmelkov, SV; Young, LM | 1 |
| Augustin, M; Franz, C; Gründer, G; Paulzen, M; Saßmannshausen, H; Schoretsanitis, G | 1 |
| Daniel, WA; Haduch, A; Papp, M; Rysz, M | 1 |
| Gruca, P; Lason, M; Litwa, E; Niemczyk, M; Papp, M; Tota-Glowczyk, K; Willner, P | 1 |
| Gotlib, IH; Kircanski, K; Williams, LM | 1 |
| El-Sahar, AE; Elbaz, EM; Helmy, HS; Saad, MA; Sayed, RH; Senousy, MA | 1 |
| Carmody, TJ; De La Garza, N; Grannemann, BD; Killian, MO; Rush, AJ; Trivedi, MH | 1 |
| Cai, WK; He, F; He, GH; Lin, XQ; Sun, M; Wang, P; Xu, GL; Yang, M; Zhou, MD | 1 |
| Hu, XY; Jiang, QS; Liu, YJ; Qiao, M; Qiu, HM; Wang, LJ; Zhou, QX | 1 |
| Cagni, FC; Costa, LRF; de Souza, IBMB; Gavioli, EC; Lima, RH; Silva Junior, ED; Tiago, PRF | 1 |
| Gruca, P; Lason, M; Niemczyk, M; Papp, M; Willner, P | 1 |
| Cipriani, A; Furukawa, TA; Ikeda, K; Imai, H; Maruo, K; Noma, H; Shinohara, K; Tanaka, S; Yamawaki, S | 1 |
| Montgomery, SA | 1 |
| Chen, XP; Lian, Z; Wang, PR; Yang, CY; Yu, LH; Zhou, YC | 1 |
| Ishibashi, T; Iwadate, R; Kawai, H; Kawashima, Y; Kudo, N; Mitsumoto, A | 1 |
| Chen, XP; Hu, XY; Liu, D; Shi, P; Wang, LJ; Xia, HJ; Zhou, QX | 1 |
| Berk, M; Bousman, CA; Byron, K; Ng, CH; Singh, AB | 1 |
| Assié, MB; Auclair, AL; Bardin, L; Cussac, D; Depoortère, R; Heusler, P; Marien, M; Martel, JC; Newman-Tancredi, A; O'Connor, JA | 1 |
| Buckley, G; Fayyad, R; Focht, K; Guico-Pabia, CJ; Kane, CP; Lobello, K; Nichols, AI; Preskorn, SH | 1 |
| Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR | 1 |
| Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A | 1 |
| Chen, W; Li, X; Wu, H; Xing, B; Yu, E | 1 |
| Charoenphandhu, J; Charoenphandhu, N; Lapmanee, S | 1 |
| Barbui, C; Godman, B; Gustafsson, LL; Miranda, J; Persson, M; Skiöld, P; Wettermark, B | 1 |
| Bech, BH; Christensen, J; Kjaersgaard, MI; Olsen, J; Parner, ET; Pedersen, LH; Sørensen, MJ; Vestergaard, M | 1 |
| Bognár, Z; Gazdag, G; Vonyik, G | 1 |
| Altman, RB; Klein, TE; Sangkuhl, K; Stingl, JC; Turpeinen, M | 1 |
| Chen, Y; Gan, J; Tan, Q; Wang, H; Xue, Y; Zhang, L; Zhang, R; Zhang, Y | 1 |
| Charlier, P; Falissard, B; Maria, AS; Millet, B; Naudet, F; Reymann, JM | 1 |
| Miller, MC | 1 |
| Davidson, RJ; Heller, AS; Johnstone, T; Kalin, NH; Kolden, GG; Peterson, MJ | 1 |
| Ali, J; Baboota, S; Haque, S; Md, S; Sahni, JK | 1 |
| Deckert, J; Hempel, S; Pfuhlmann, B; Proft, F; Reif, A; Riederer, P; Unterecker, S | 1 |
| Bombardier, CH; Brooks, L; Bryce, TN; Chiodo, A; Dijkers, MP; Fann, JR; Forchheimer, M; Richards, JS; Tate, DG | 1 |
| Deuschle, M; Gilles, M; Hamann, B; Lederbogen, F; Paslakis, G; Westphal, S | 1 |
| Auinger, P; Christine, CW; Factor, SA; Juncos, J; Leentjens, AF; Lyness, JM; Marsh, L; McDonald, W; Moonen, AJ; Panisset, M; Pfeiffer, R; Richard, IH; Rottenberg, D; Serrano Ramos, C; Shulman, L; Singer, C; Slevin, J; Wijers, A | 1 |
| Dew, MA; Karp, JF; Rej, S | 1 |
| Huang, X; Ji, JL; Li, C; Mao, YS; Wang, H | 2 |
| An, Y; Li, M; Li, X; Lin, L; Ren, J; Yun, K; Zhang, H; Zhang, X | 1 |
| Chen, J; Gong, W; Li, Z; Mu, J; Shao, W; Wu, Q; Xie, P; Xu, F; Yang, D; Yang, J; Yang, Y; Zhang, J | 1 |
| Ivanets, NN; Iziumina, TA; Kinkulkina, MA; Tikhonova, YG | 1 |
| Chen, C; Chen, F; Lu, YN; Zhai, XJ; Zhu, CR | 1 |
| Aisa, B; Martisova, E; Puerta, E; Ramirez, MJ; Solas, M; Tordera, RM | 1 |
| Acar, H; Acikalin, RM; Karatas, A; Salviz, M; Yuce, T | 1 |
| Ashton, T; Davis, P; Lessing, C | 1 |
| Asadi, M; Davari-Tanha, F; Hadizadeh, H; Shariat, M; Shirazi, M; Soleymani-Farsani, M | 1 |
| Chang, CL; Dore, DD; Li, H; Lin, ND; Norman, H; Perahia, DG; Regev, A | 1 |
| Cetiner Batun, G; Elmali, AD; Emul, M; Vatankulu, B; Yuruyen, M | 1 |
| Broadbent, M; McGuire, P; Patel, R; Reiss, P; Shetty, H; Stewart, R; Taylor, M | 1 |
| Arns, M; Boutros, NN; Gordon, E | 1 |
| Broen, MP; Köhler, S; Kuijf, ML; Leentjens, AF; McDonald, WM; Richard, IH | 1 |
| Fancourt, N; Ging, JM; Nelson, TY; Sharma, R; Tantsis, EM; Tran, MM | 1 |
| Ramzy, EA | 1 |
| García-Pérez, I; Meléndez-Camargo, ME; Serrano-Contreras, JI; Zepeda-Vallejo, LG | 1 |
| Antoniów, M; Grześkowiak, E; Kus, K; Nowakowska, E; Ratajczak, P; Szkutnik-Fiedler, D | 1 |
| Etkin, A; Gyurak, A; Harris, A; Shilyansky, C; Usherwood, T; Williams, LM | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Chang, LR; Chen, IM; Chen, TT; Huang, WL; Kuo, TB; Liao, SC; Yang, CC | 1 |
| Aizenstein, HJ; Andreescu, C; Butters, MA; Karim, HT; Karp, JF; Reynolds, C; Smagula, SF; Tudorascu, D | 1 |
| Capron, A; Castanares-Zapatero, D; Gillard, N; Hantson, P; Haufroid, V | 1 |
| Huang, S; Liu, C; Liu, X; Ye, Y | 1 |
| Domingues, DS; Miranda, LF; Queiroz, ME | 1 |
| Bailine, SH; Briggs, MC; Geduldig, ET; Greenberg, RM; Husain, MM; Kaliora, S; Kellner, CH; Knapp, RG; Latoussakis, V; Liebman, LS; Lisanby, SH; McCall, WV; McClintock, SM; Mueller, M; Petrides, G; Prudic, J; Raza, A; Rosenquist, PB; Rudorfer, MV; Sampson, S; Teklehaimanot, AA; Tobias, KG; Weiner, RD; Young, RC | 1 |
| Bailine, SH; Briggs, MC; Dooley, M; Geduldig, ET; Greenberg, RM; Husain, MM; Kaliora, S; Kellner, CH; Knapp, RG; Latoussakis, V; Liebman, LS; Lisanby, SH; McCall, WV; McClintock, SM; Mueller, M; Petrides, G; Prudic, J; Raza, A; Rosenquist, PB; Rudorfer, MV; Sampson, S; Teklehaimanot, AA; Tobias, KG; Weiner, RD; Young, RC | 1 |
| Bai, S; Cheng, K; Dong, M; Han, Y; Hu, Q; Li, J; Liang, Z; Shen, P; Wang, H; Wang, W; Wang, X; Xie, P; Zhang, S; Zou, D | 1 |
| Madias, JE | 1 |
| Bech, P; Carlsson, J; Elklit, A; Mortensen, EL; Sonne, C | 1 |
| Dong, J; Gu, JY; Li, Y; Ning, QF; Shan, XW; Wang, CH; Yang, J; Zhang, XL; Zhang, YL | 1 |
| Necpál, J; Skorvanek, M | 1 |
| Kräenbring, J; Warninghoff, J; Zellner, N | 1 |
| Chen, J; Deng, X; Fang, L; Lei, T; Lei, Y; Qu, Z; Zhang, L; Zhao, X; Zhong, J; Zhou, C; Zou, B | 1 |
| Kelly, BD | 1 |
| Dhir, A; Kulkarni, SK | 2 |
| Bootzin, E; Millan, MJ; O'Donnell, JM; Zhang, HT; Zhao, Z | 1 |
| Joeris, A; Kessler, U; Nelle, M; Schwendener Scholl, K; Treichel, M | 1 |
| Il'ina, NA | 2 |
| Begré, S; Gerber, M; Traber, M; von Känel, R | 2 |
| Arneth, B; Härtter, S; Hiemke, C; Shams, M | 1 |
| Bolton, JM; Leung, S; Metge, CJ; Sareen, J; Targownik, LE | 1 |
| Cook, IA; Hunter, AM; Korb, AS; Leuchter, AF | 1 |
| Bekers, O; Drent, M; Koek, GH; Kuijpers, PM; Limantoro, I; Wijnen, PA | 1 |
| De Roover, A; Delbouille, MH; Delwaide, J; Detry, O; Hans, MF; Honoré, P; Monard, J | 1 |
| Deuschle, M; Gilles, M; Hamann-Weber, B; Kopf, D; Lederbogen, F; Luppa, P; Paslakis, G | 1 |
| Bortolatto, CF; Jesse, CR; Nogueira, CW; Wilhelm, EA | 1 |
| Despiégel, N; François, C; Guelfucci, F; Saragoussi, D; Toumi, M; Wade, AG | 1 |
| Caroselli, C; Ricci, G | 1 |
| Kim, JH; Kim, JJ; Kim, S; Lee, H; Lee, JH; Min, BH; Rhee, JC; Rhee, PL; Son, HJ; Suh, YJ | 1 |
| Christoph, M; Ebner, B; Ibrahim, K; Kolschmann, S; Schön, S; Stolte, D; Strasser, RH | 1 |
| Fujiwara, M; Fujiwara, S; Ide, S; Ikeda, K; Ishihara, K; Minami, M; Sora, I; Uhl, GR | 1 |
| Bérard, A; Ramos, É; St-André, M | 1 |
| Krass, M; Vasar, E; Volke, V; Wegener, G | 1 |
| Dhir, A; Kessar, SV; Kulkarni, SK; Malik, S; Singh, KN | 1 |
| Berk, M; Liu, X; Wang, Y; Xiao, Z | 1 |
| Iastrebov, DV | 1 |
| Ding, ZB; Lu, L; Shi, HS; Wang, SJ; Wu, P; Zhu, WL | 1 |
| Bobo, WV; Chen, H; Cook, IA; Fava, M; Husain, MM; Kornstein, SG; Kurian, BT; Lesser, IM; Luther, JF; Morris, DW; Nierenberg, AA; Rush, AJ; Shelton, RC; Stewart, JW; Trivedi, MH; Warden, D; Wisniewski, SR | 1 |
| Du, G; Gao, X; Guo, X; Li, Z; Qin, X; Sun, H; Zhang, L; Zheng, X; Zhou, Y | 1 |
| Cure, MC; Demirdas, A; Eren, I; Kirbas, A; Sutcu, R; Yilmaz, M; Yilmaz, N | 1 |
| Bacq, A; Balasse, L; Biala, G; Chevarin, C; Gardier, AM; Gautron, S; Giros, B; Guiard, B; Hamon, M; Louis, F; Martres, MP; Schinkel, A; Vialou, V | 1 |
| Abdel-Wahab, BA; Salama, RH | 1 |
| Cuestas, E; Cuestas, ME | 1 |
| Dai, MH; Han, Y; Li, DQ | 1 |
| Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Nakagawa, A; Omori, IM; Watanabe, N | 1 |
| Horrillo, I; Martisova, E; Meana, JJ; Ortega, JE; Ramírez, MJ; Solas, M; Tordera, RM | 1 |
| Amsterdam, J; Guerra, MW; Shults, J; Ten-Have, T | 1 |
| Baker, RA; Bennetts, JS; Cardinal, T; Tully, PJ | 1 |
| Karp, JF; Lotrich, F; Mazumdar, S; Morone, N; Morse, JQ; Reynolds, CF; Rollman, BL; Weiner, DK | 1 |
| Liu, J; Qiao, W; Ren, L; Sun, Y; Wang, S; Yang, Y | 1 |
| Badin, J; Bretaudeau Deguigne, M; Francino, MC; Perrotin, D; Turcant, A | 1 |
| Cui, J; Du, GH; Gao, XX; Li, ZF; Li, ZY; Liu, XJ; Qin, XM; Sun, HF; Zhang, LZ; Zhou, YZ | 1 |
| Chen, YC; Feng, SF; Shi, TY; Tan, QR; Wang, WN | 1 |
| Delagrange, P; Elizalde, N; García-García, AL; Tordera, RM; Venzala, E | 1 |
| Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; Imperadore, G; Purgato, M; Signoretti, A; Trespidi, C; Watanabe, N | 1 |
| Liu, XH; Qin, J; Wang, Y; Wen, ZY; Yang, JL; Yu, JJ; Zhang, Y | 1 |
| Fennell, J; Grocott, MP; Sevastru, S; Wakatsuki, M | 1 |
| Campbell, JJ; George, M | 1 |
| Shahani, L | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Koesters, M; Nosè, M; Omori, IM; Purgato, M; Trespidi, C | 1 |
| Ghio, L; Presta, A; Puppo, S | 1 |
| Blum, WF; Colla, M; Daseking, E; Deuschle, M; Gilles, M; Heuser, I; Kopf, D; Krumm, B; Lederbogen, F; Schilling, C; Weber-Hamann, B; Wudy, SA | 1 |
| Li, L; Lin, M; Qian, MC; Shen, XH; Sun, JS; Yang, JH; Zhang, J; Zhong, H | 1 |
| Gibson-Helm, M; Sayakhot, P; Teede, HJ; Vincent, A | 1 |
| Feng, W; Fenli, S; Huande, L; Ronghua, Z | 1 |
| Koerselman, GF; van Noorden, MS; Vergouwen, AC | 1 |
| Jha, A; Tomar, R | 1 |
| Crystal, S; Olfson, M; Sambamoorthi, U; Walkup, JT | 1 |
| de Moor, RA; Egberts, AC; Mourad, L; ter Haar, J | 1 |
| Fava, GA; Mangelli, L | 1 |
| Blahak, C; Capelle, HH; Grips, E; Krauss, JK; Weigel, R; Wöhrle, JC | 1 |
| Roxanas, MG | 1 |
| Ak, I; Aksu, G; Sayar, K; Tosun, M | 1 |
| Baudendistel, TE; Khurana, RN | 1 |
| Alloui, A; Ardid, D; Constandil, L; Eschalier, A; Hernández, A; Laurido, C; Marchand, F; Pelissier, T; Soto-Moyano, R | 1 |
| Bond, GR; Steele, PE; Uges, DR | 1 |
| Norman, TR; Olver, JS | 1 |
| Chae, JH; Kim, JJ; Lee, C; Lee, CU; Lee, SJ; Pae, CU; Paik, IH | 1 |
| Brandes, M; Cassano, P; Cohen, LS; Leblanc, GA; Lyster, A; Soares, CN | 1 |
| Devanand, D; Fitzsimmons, L; Miyazaki, M; Roose, SP; Sackeim, H; Seidman, S; Turret, N | 1 |
| Yanik, M | 1 |
| de Guzman, MH; Goldberg, I; Ong, PY; Thiagalingam, S | 1 |
| Ding, BK; Jin, KH; Ma, H; Qin, XS; Xie, SF | 1 |
| Huande, L; Juan, H; Zhiling, Z | 1 |
| Eloranta, A; Hallikainen, T; Repo-Tiihonen, E; Tiihonen, J | 1 |
| Han, D; Wang, EC | 1 |
| Fehér, LZ; Galsi, G; Hugyecz, M; Janka, Z; Juhász, A; Kálmán, J; Kovács, Z; Pákáski, M; Palotás, A; Puskás, LG; Rimanóczy, A; Szabó, Z | 1 |
| Bexton, B; Han, D; Lelorier, J; Monfared, AA; Sheehy, O | 1 |
| Efremidis, M; Evangelou, D; Kardaras, F; Korantzopoulos, P; Letsas, K; Pappas, L | 1 |
| Czubak, A; Florek, E; Jodynis-Liebert, J; Kus, K; Nowakowska, E | 1 |
| Cottraux, J | 1 |
| Abozguia, K; Chudley, S; Gammage, M | 1 |
| Cai, HL; Li, HD; Liu, W | 1 |
| Altunbaşak, A; Celik, O; Demirdaş, A; Eren, I; Naziroğlu, M; Ozmen, I; Uğuz, AC; Uz, E | 1 |
| Allgulander, C; Sheehan, DV | 1 |
| Ahmed, S; Dunlop, BW; Dunner, DL; Ferguson, JM; Friedman, ES; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kocsis, JH; Kornstein, SG; Nemeroff, CB; Ninan, PT; Pedersen, R; Rothschild, AJ; Schatzberg, AF; Schmidt, M; Shelton, RC; Thase, ME; Trivedi, MH; Yan, B; Zajecka, JM | 1 |
| Aviv, A; Barak, Y; Mazeh, D; Shahal, B; Zemishlani, H | 1 |
| Altindag, A; Gunes, M | 1 |
| Jürgens, TP; Koch, HJ; Leinisch, E | 1 |
| Jiang, Q; Lenox-Smith, AJ | 1 |
| Aparicio, N; De Boer, WA; Jansen, JB; Laheij, RJ; Tan, AC; Van den Hazel, S; van Kerkhoven, LA; Witteman, BJ | 1 |
| Derivan, A; Entsuah, AR; Kikta, D | 1 |
| Benfield, P; Holliday, SM | 1 |
| Ellingrod, VL; Perry, PJ | 1 |
| Baumel, B; Ferguson, J; Khan, A; Rudolph, R; Ryan, P; Shrivastava, R | 1 |
| Dierick, M | 1 |
| Entsuah, R | 1 |
| Blanchard, C; Bourin, M; Danjou, P; Hackett, D; Lecrubier, Y; Moon, CA; Schifano, F | 1 |
| Karki, SD; Masood, GR; Patterson, WR | 1 |
| Ansseau, M | 1 |
| Boyd, IW | 1 |
| Béïque, JC; Blier, P; de Montigny, C; Debonnel, G | 1 |
| Dahmen, N; Hopf, HC; Marx, J; Röder, R; Tettenborn, B | 1 |
| Elizur, A; Mazeh, D; Melamed, Y | 1 |
| Schwartz, TL | 1 |
| Brown, ES; Hong, SC | 1 |
| Samuel, RZ | 1 |
| Gregson, J | 1 |
| Gunning, K; Magill, MK | 1 |
| Cook, IA; Leuchter, AF | 1 |
| Brown, WA; Khan, A; Khan, SR; Leventhal, RM | 1 |
| Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S | 1 |
| Morrow, TJ | 1 |
| Dunn, AJ; Swiergiel, AH | 1 |
| Ismail, M; Lyster, G | 1 |
| Höfler, M; Hoyer, J; Krause, P; Wittchen, HU | 1 |
| Pallay, AG; Pedersen, RD; Rudolph, RL | 1 |
| Finnerty, R; Goldberg, HL | 1 |
22 review(s) available for venlafaxine hydrochloride and Depression
| Article | Year |
|---|---|
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Depression; Humans; Lithium; Randomized Controlled Trials as Topic; Sertraline; Venlafaxine Hydrochloride | 2022 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
Systematic evaluation of the 'efficacy-effectiveness gap' in the treatment of depression with venlafaxine and duloxetine.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Prospective Studies; Venlafaxine Hydrochloride | 2021 |
The Associations Between CYP2D6 Metabolizer Status and Pharmacokinetics and Clinical Outcomes of Venlafaxine: A Systematic Review and Meta-Analysis.
Topics: Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6; Depression; Humans; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
PharmGKB summary: venlafaxine pathway.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Depression; Genetic Variation; Genotype; Humans; Metabolic Networks and Pathways; Mice; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Substrate Specificity; Venlafaxine Hydrochloride | 2014 |
Which placebo to cure depression? A thought-provoking network meta-analysis.
Topics: Antidepressive Agents; Biomedical Research; Clinical Trials as Topic; Cyclohexanols; Depression; Fluoxetine; Humans; Placebos; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Humans; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Venlafaxine Hydrochloride | 2017 |
Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?
Topics: Colectomy; Colon; Cyclohexanols; Depression; Enterocolitis, Necrotizing; Female; Humans; Ileum; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Twins; Venlafaxine Hydrochloride | 2009 |
Mirtazapine versus other antidepressive agents for depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Humans; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2011 |
Citalopram versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Humans; Morpholines; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Duloxetine versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Desvenlafaxine Succinate; Dibenzothiazepines; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiophenes; Venlafaxine Hydrochloride | 2012 |
New formulations of existing antidepressants: advantages in the management of depression.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chemistry, Pharmaceutical; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Evaluation; Fluoxetine; Humans; Mianserin; Mirtazapine; Molecular Conformation; Venlafaxine Hydrochloride | 2004 |
Remission from depression : a review of venlafaxine clinical and economic evidence.
Topics: Antidepressive Agents, Second-Generation; Cost of Illness; Cyclohexanols; Depression; Humans; Remission Induction; Secondary Prevention; Venlafaxine Hydrochloride | 2005 |
[Psychotherapies: what is the impact on the cortical and subcortical levels?].
Topics: Brain; Cyclohexanols; Depression; Humans; Obsessive-Compulsive Disorder; Phobic Disorders; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
Generalized anxiety disorder: raising the expectations of treatment.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
[A clinical challenge. Pragmatic treatment of migraine and concomitant depression].
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiemetics; Arrhythmias, Cardiac; Cross-Over Studies; Cyclohexanols; Depression; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Fluoxetine; Humans; Migraine Disorders; Polypharmacy; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2008 |
Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Cardiovascular System; Central Nervous System; Cyclohexanols; Depression; Dosage Forms; Dose-Response Relationship, Drug; Drug Interactions; Humans; Synaptic Transmission; Venlafaxine Hydrochloride | 1995 |
Venlafaxine: a heterocyclic antidepressant.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclohexanols; Depression; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1994 |
Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trial.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Data Interpretation, Statistical; Depression; Humans; Longitudinal Studies; Mathematical Computing; Software; Statistics as Topic; Venlafaxine Hydrochloride | 1996 |
The pharmacoeconomics of venlafaxine in depression.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cost-Benefit Analysis; Cyclohexanols; Depression; Drug Utilization Review; Humans; Managed Care Programs; Selective Serotonin Reuptake Inhibitors; United States; Venlafaxine Hydrochloride | 2001 |
55 trial(s) available for venlafaxine hydrochloride and Depression
| Article | Year |
|---|---|
Predicting Medication Nonadherence in Older Adults With Difficult-to-Treat Depression in the IRL-GRey Randomized Controlled Trial.
Topics: Aged; Antidepressive Agents; Depression; Depressive Disorder, Major; Humans; Medication Adherence; Venlafaxine Hydrochloride | 2022 |
Emotional blunting with bupropion and serotonin reuptake inhibitors in three randomized controlled trials for acute major depressive disorder.
Topics: Adult; Antidepressive Agents; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2022 |
Impact of response shift effects in the assessment of self-reported depression during treatment: Insights from a rTMS versus Venlafaxine randomized controlled trial.
Topics: Depression; Depressive Disorder, Major; Humans; Self Report; Treatment Outcome; Venlafaxine Hydrochloride | 2023 |
VE-MMODE - A randomized controlled trial of Venlafaxine versus Escitalopram for treatment of mild to moderate depression in persons with epilepsy.
Topics: Adolescent; Depression; Double-Blind Method; Epilepsy; Escitalopram; Humans; Seizures; Treatment Outcome; Venlafaxine Hydrochloride | 2023 |
Opioid Exposure Negatively Affects Antidepressant Response to Venlafaxine in Older Adults with Chronic Low Back Pain and Depression.
Topics: Aged; Analgesics, Opioid; Antidepressive Agents; Chronic Pain; Depression; Humans; Low Back Pain; Venlafaxine Hydrochloride | 2020 |
Comorbid anxiety in late-life depression: Relationship with remission and suicidal ideation on venlafaxine treatment.
Topics: Aged; Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Depressive Disorder, Major; Female; Humans; Logistic Models; Male; Middle Aged; Suicidal Ideation; Survival Analysis; Venlafaxine Hydrochloride | 2019 |
Psychomotor Retardation and the prognosis of antidepressant treatment in patients with unipolar Psychotic Depression.
Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Humans; Prognosis; Psychotic Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy: Individual patient data analysis.
Topics: Antidepressive Agents; Cluster Analysis; Cyclohexanols; Data Analysis; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Effect of Metabolic Syndrome on Late-Life Depression: Associations with Disease Severity and Treatment Resistance.
Topics: Age Factors; Aged; Antidepressive Agents, Second-Generation; Depression; Drug Resistance; Female; Humans; Male; Metabolic Syndrome; Severity of Illness Index; Venlafaxine Hydrochloride | 2017 |
Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Carrier Proteins; Citalopram; Depression; Female; Genotype; Homozygote; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2018 |
Validating pre-treatment body mass index as moderator of antidepressant treatment outcomes: Findings from CO-MED trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biomarkers; Body Mass Index; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Overweight; Patient Selection; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
Effect of Problem-Solving Therapy Versus Supportive Management in Older Adults with Low Back Pain and Depression While on Antidepressant Pharmacotherapy.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Combined Modality Therapy; Depression; Female; Humans; Low Back Pain; Male; Middle Aged; Problem Solving; Psychotherapy; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Biomarkers; Citalopram; Depression; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Prognosis; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2019 |
The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
Topics: Adult; Aged; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Psychometrics; Risk Assessment; Self Report; Single-Blind Method; Suicidal Ideation; Venlafaxine Hydrochloride | 2019 |
[Therapeutic effect of the combined treatment with acupuncture and venlafaxine hydrochloride on depression based on diffusion tensor imaging technology].
Topics: Acupuncture Therapy; Brain; Depression; Diffusion Tensor Imaging; Humans; Prospective Studies; Venlafaxine Hydrochloride | 2019 |
Cytochrome P450 2D6 phenoconversion is common in patients being treated for depression: implications for personalized medicine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Phenotype; Precision Medicine; Venlafaxine Hydrochloride | 2013 |
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult | 2013 |
Efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of depression: study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; China; Clinical Protocols; Combined Modality Therapy; Cyclohexanols; Depression; Humans; Middle Aged; Psychiatric Status Rating Scales; Research Design; Secondary Prevention; Severity of Illness Index; Single-Blind Method; Time Factors; Transcranial Magnetic Stimulation; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depression; Depressive Disorder, Major; Double-Blind Method; Emotions; Fluoxetine; Functional Neuroimaging; Humans; Prefrontal Cortex; Venlafaxine Hydrochloride | 2013 |
Screening for neuropathic pain after spinal cord injury with the spinal cord injury pain instrument (SCIPI): a preliminary validation study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cross-Sectional Studies; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Principal Component Analysis; Psychometrics; Reproducibility of Results; ROC Curve; Self Report; Spinal Cord Injuries; Surveys and Questionnaires; United States; Venlafaxine Hydrochloride; Young Adult | 2014 |
Unstimulated and glucose-stimulated ghrelin in depressed patients and controls.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Appetite Regulation; Biomarkers; Blood Glucose; Depression; Female; Ghrelin; Glucose Tolerance Test; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of "easy-to-use" clinical predictors of early response.
Topics: Aged; Antidepressive Agents, Second-Generation; Chronic Pain; Cyclohexanols; Depression; Female; Humans; Low Back Pain; Male; Treatment Outcome; Venlafaxine Hydrochloride | 2014 |
Propranolol and venlafaxine for vestibular migraine prophylaxis: A randomized controlled trial.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Middle Aged; Migraine Disorders; Propranolol; Prospective Studies; Vasodilator Agents; Venlafaxine Hydrochloride; Vestibular Diseases | 2016 |
Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Topics: Citalopram; Depression; Double-Blind Method; Female; Hot Flashes; Humans; Iran; Middle Aged; Postmenopause; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Severity of Illness Index; Sleep; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression; Electroencephalography; Female; Humans; Internationality; Male; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2017 |
Trajectories of recovery in depressed Parkinson's disease patients treated with paroxetine or venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Venlafaxine Hydrochloride | 2016 |
Comparative Efficacy of Newer Antidepressants in Combination with Pregabalin for Fibromyalgia Syndrome: A Controlled, Randomized Study.
Topics: Adult; Amitriptyline; Antidepressive Agents; Depression; Drug Therapy, Combination; Female; Fibromyalgia; Humans; Male; Middle Aged; Paroxetine; Pregabalin; Quality of Life; Venlafaxine Hydrochloride | 2017 |
Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cognitive Dysfunction; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2016 |
Right Unilateral Ultrabrief Pulse ECT in Geriatric Depression: Phase 1 of the PRIDE Study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Depression; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
A Novel Strategy for Continuation ECT in Geriatric Depression: Phase 2 of the PRIDE Study.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Depression; Double-Blind Method; Electroconvulsive Therapy; Female; Humans; Lithium; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Denmark; Depression; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Refugees; Research Design; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Biomarkers; Brain Mapping; Cerebral Cortex; Cyclohexanols; Depression; Double-Blind Method; Electroencephalography; Female; Fluoxetine; Gyrus Cinguli; Humans; Male; Middle Aged; Theta Rhythm; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2009 |
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment.
Topics: Adult; Age Factors; Aged; Analysis of Variance; Antidepressive Agents; Case-Control Studies; Cyclohexanols; Dehydroepiandrosterone Sulfate; Depression; Female; Humans; Hydrocortisone; Male; Mianserin; Middle Aged; Mirtazapine; Saliva; Secondary Prevention; Sex Factors; Venlafaxine Hydrochloride | 2010 |
Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
Topics: Adult; Anxiety; Chest Pain; Chi-Square Distribution; Cross-Over Studies; Cyclohexanols; Delayed-Action Preparations; Depression; Double-Blind Method; Esophageal Diseases; Esophageal pH Monitoring; Female; Humans; Male; Manometry; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
[Treatment-resistant depressions in borderline psychiatry].
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Administration Schedule; Drug Resistance; Female; Humans; Male; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2011 |
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Depression; Depressive Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
Addressing both depression and pain in late life: the methodology of the ADAPT study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Comorbidity; Cyclohexanols; Depression; Female; Humans; Low Back Pain; Male; Middle Aged; Problem Solving; Research Design; Venlafaxine Hydrochloride | 2012 |
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Biomarkers; Body Mass Index; Cyclohexanols; Depression; Female; Humans; Leptin; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Time Factors; Treatment Outcome; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain; Young Adult | 2013 |
[Effects of apolipoprotein E genetic polymorphism on susceptibility of depression and efficacy of antidepressants].
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Apolipoproteins E; Cyclohexanols; Depression; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2012 |
Venlafaxine treatment of fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety; Cyclohexanols; Depression; Female; Fibromyalgia; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Luteal Phase; Premenstrual Syndrome; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
An open trial of venlafaxine for the treatment of late-life atypical depression.
Topics: Age of Onset; Aged; Antidepressive Agents; Chi-Square Distribution; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 2004 |
Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chromatography, High Pressure Liquid; Clozapine; Cyclohexanols; Depression; Humans; Male; Middle Aged; Schizophrenia; Venlafaxine Hydrochloride | 2005 |
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Nausea; Paroxetine; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia | 2007 |
Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
Topics: Adult; Antidepressive Agents, Second-Generation; Australia; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Europe; Female; Humans; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Failure; Venlafaxine Hydrochloride | 2008 |
Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Dyspepsia; Female; Humans; Male; Middle Aged; Placebos; Quality of Life; Venlafaxine Hydrochloride | 2008 |
Venlafaxine: measuring the onset of antidepressant action.
Topics: Antidepressive Agents; Cyclohexanols; Depression; Follow-Up Studies; Humans; Placebo Effect; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 1995 |
Venlafaxine in depressed geriatric outpatients: an open-label clinical study.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1995 |
An open-label evaluation of the long-term safety of oral venlafaxine in depressed elderly patients.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Electrocardiography; Female; Humans; Male; Sampling Studies; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Efficacy of venlafaxine in depressive illness in general practice.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Placebo Effect; Prospective Studies; Social Adjustment; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Therapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trial.
Topics: Aged; Antidepressive Agents, Second-Generation; Cerebrovascular Disorders; Cyclohexanols; Depression; Female; Humans; Male; Venlafaxine Hydrochloride | 1999 |
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Databases, Factual; Depression; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide Prevention; Suicide, Attempted; United States; United States Food and Drug Administration; Venlafaxine Hydrochloride | 2001 |
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Can improvement in well-being and functioning be distinguished from depression improvement in antidepressant clinical trials?
Topics: Activities of Daily Living; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Controlled Clinical Trials as Topic; Cyclohexanols; Depression; Factor Analysis, Statistical; Female; Humans; Imipramine; Male; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Venlafaxine Hydrochloride | 2002 |
176 other study(ies) available for venlafaxine hydrochloride and Depression
| Article | Year |
|---|---|
Insufficiency of ventral hippocampus to medial prefrontal cortex transmission explains antidepressant non-response.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Hippocampus; Male; Maze Learning; Optogenetics; Prefrontal Cortex; Rats; Rats, Inbred WKY; Stress, Psychological; Venlafaxine Hydrochloride | 2021 |
Comparison of inflammatory markers as moderators of depression outcomes: A CO-MED study.
Topics: Biomarkers; Citalopram; Depression; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Do greater levels of in-cage waking inactivity in laboratory mice reflect a spontaneous depression-like symptom? A pharmacological investigation.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Depression; Environment; Female; Housing, Animal; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Motor Activity; Venlafaxine Hydrochloride | 2022 |
Early intervention of acute liver injury related to venlafaxine: A case report.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Chemical and Drug Induced Liver Injury; Depression; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Liver; Ultrasonography; Venlafaxine Hydrochloride | 2021 |
Association between mirtazapine use and serious self-harm in people with depression: an active comparator cohort study using UK electronic health records.
Topics: Amitriptyline; Antidepressive Agents; Cohort Studies; Depression; Electronic Health Records; Humans; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Suicide; United Kingdom; Venlafaxine Hydrochloride | 2022 |
Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: Two case reports.
Topics: Aged; Aged, 80 and over; Depression; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Mianserin; Pain; Venlafaxine Hydrochloride | 2022 |
Sleep deprivation leads to further impairment of hippocampal synaptic plasticity by suppressing melatonin secretion in the pineal gland of chronically unpredictable stress rats.
Topics: Animals; Depression; Hippocampus; Melatonin; Neuronal Plasticity; Pineal Gland; Rats; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Stress, Psychological; Venlafaxine Hydrochloride | 2022 |
Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals.
Topics: Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Depression; Donepezil; Dothiepin; Frontotemporal Dementia; Hospitals; Humans; Lamotrigine; Memantine; Mirtazapine; NAD; Sertraline; Valproic Acid; Venlafaxine Hydrochloride; Wales | 2022 |
Optogenetic stimulation of transmission from prelimbic cortex to nucleus accumbens core overcomes resistance to venlafaxine in an animal model of treatment-resistant depression.
Topics: Animals; Antidepressive Agents; Depression; Models, Animal; Nucleus Accumbens; Optogenetics; Prefrontal Cortex; Rats; Rats, Inbred WKY; Venlafaxine Hydrochloride | 2023 |
The alteration of gut microbiota in venlafaxine-ameliorated chronic unpredictable mild stress-induced depression in mice.
Topics: Animals; Antidepressive Agents; Bacteria; Depression; Disease Models, Animal; Gastrointestinal Microbiome; Hippocampus; Mice; Serotonin; Stress, Psychological; Venlafaxine Hydrochloride | 2023 |
Estimating the prevalence of depression using wastewater-based epidemiology: A case study in Qinghai Province, West China.
Topics: Antidepressive Agents; China; Depression; Paroxetine; Prevalence; Sertraline; Venlafaxine Hydrochloride; Wastewater; Water Pollutants, Chemical | 2023 |
Venlafaxine's effect on resilience to stress is associated with a shift in the balance between glucose and fatty acid utilization.
Topics: Anhedonia; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Glucose; Hippocampus; Humans; Rats; Rats, Wistar; Stress, Psychological; Venlafaxine Hydrochloride | 2023 |
Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Mianserin; Mice; Mirtazapine; Moclobemide; Naloxone; Reboxetine; Trazodone; Venlafaxine Hydrochloride | 2023 |
Malic Acid Improves Behavioral, Biochemical, and Molecular Disturbances in the Hypothalamus of Stressed Rats.
Topics: Animals; Depression; Hypothalamus; Male; Oxidative Stress; Rats; Saline Solution; Stress, Psychological; Venlafaxine Hydrochloride | 2023 |
Hippocampal PPARα is involved in the antidepressant-like effects of venlafaxine in mice.
Topics: Animals; Antidepressive Agents; Brain; Depression; Depressive Disorder; Hippocampus; Male; Mice; Mice, Inbred C57BL; PPAR alpha; Prefrontal Cortex; Stress, Psychological; Temporal Lobe; Venlafaxine Hydrochloride | 2019 |
Piperlongumine produces antidepressant-like effects in rats exposed to chronic unpredictable stress.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Cytokines; Depression; Dioxolanes; Disease Models, Animal; Hippocampus; Male; Motor Activity; Neuroprotective Agents; Rats; Stress, Psychological; Venlafaxine Hydrochloride | 2019 |
Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Case-Control Studies; Cohort Studies; Depression; Diabetes, Gestational; Female; Gestational Age; Humans; Logistic Models; Pregnancy; Quebec; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Young Adult | 2019 |
The combination of mirtazapine plus venlafaxine reduces immobility in the forced swim test and does not inhibit female sexual behavior.
Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Locomotion; Male; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Sexual Behavior, Animal; Swimming; Venlafaxine Hydrochloride | 2019 |
Transient left ventricular hypertrophy in a 30-year-old female with chronic emotional stress and depression treated with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cardiomyopathy, Hypertrophic; Contrast Media; Depression; Female; Gadolinium; Humans; Hypertrophy, Left Ventricular; Stress, Psychological; Venlafaxine Hydrochloride | 2019 |
Neurocognitive Effects of Electroconvulsive Therapy-What Do Patients and Clinicians Need to Know?
Topics: Aged; Depression; Depressive Disorder, Treatment-Resistant; Electroconvulsive Therapy; Humans; Venlafaxine Hydrochloride | 2020 |
Recurrence of Serotonin Toxicity and Influence of Cytochrome 2D6 Polymorphism.
Topics: Antidepressive Agents; Cognitive Dysfunction; Cytochrome P-450 CYP2D6; Depression; Humans; Male; Middle Aged; Polymorphism, Genetic; Recurrence; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2019 |
Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxine.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Biomarkers; Cohort Studies; Depression; Female; Humans; Male; MicroRNAs; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Pharmacological management of depression: Japanese expert consensus.
Topics: Antidepressive Agents; Consensus; Depression; Humans; Japan; Venlafaxine Hydrochloride | 2020 |
Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.
Topics: Aged; Antidepressive Agents; Depression; Female; Fractures, Bone; Humans; Male; North America; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Taiwan; United Kingdom; Venlafaxine Hydrochloride | 2020 |
Pre-pubertal, low-intensity exercise does not require concomitant venlafaxine to induce robust, late-life antidepressant effects in Flinders sensitive line rats.
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder, Major; Disease Models, Animal; Norepinephrine; Rats; Serotonin; Venlafaxine Hydrochloride | 2020 |
The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report.
Topics: Activation, Metabolic; Adult; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Depression; Drug Monitoring; Duloxetine Hydrochloride; Female; Genotype; Humans; Inactivation, Metabolic; Pharmacogenetics; Pharmacogenomic Variants; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2020 |
Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.
Topics: Aged; Depression; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Effect of concurrent organic cation transporter blockade on norepinephrine clearance inhibiting- and antidepressant-like actions of desipramine and venlafaxine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Dentate Gyrus; Depression; Desipramine; Disease Models, Animal; Locomotion; Male; Mice, Inbred C57BL; Norepinephrine; Organic Cation Transport Proteins; Quinolines; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2020 |
Venlafaxine protects against chronic stress-related behaviors in mice by activating the mTORC1 signaling cascade.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Hippocampus; Mice; Mice, Inbred C57BL; Signal Transduction; Stress, Psychological; Venlafaxine Hydrochloride | 2020 |
Unravelling the antimicrobial action of antidepressants on gut commensal microbes.
Topics: Akkermansia; Antidepressive Agents; Bacteroides fragilis; Bifidobacterium animalis; Depression; Desipramine; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gastrointestinal Microbiome; Humans; Microbial Sensitivity Tests; Phenelzine; Venlafaxine Hydrochloride | 2020 |
[The use of neuroprotectors in the treatment of late depression].
Topics: Aged; Antidepressive Agents; Anxiety; Depression; Depressive Disorder; Humans; Middle Aged; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients With Depression.
Topics: Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6; Depression; Desvenlafaxine Succinate; Genotype; Humans; Japan; Venlafaxine Hydrochloride | 2021 |
Venlafaxine reduces the striatal il6/il10 ratio and increases hippocampal GR expression in female mice subjected to chronic social instability stress.
Topics: Animals; Corticosterone; Depression; Female; Hippocampus; Interleukin-10; Interleukin-6; Mice; Stress, Psychological; Venlafaxine Hydrochloride | 2021 |
Venlafaxine and L-Thyroxine Treatment Combination: Impact on Metabolic and Synaptic Plasticity Changes in an Animal Model of Coexisting Depression and Hypothyroidism.
Topics: Animals; Depression; Disease Models, Animal; Drug Therapy, Combination; Frontal Lobe; Humans; Hypothyroidism; Male; Neuronal Plasticity; Rats; Rats, Inbred WKY; Thyroxine; Venlafaxine Hydrochloride | 2021 |
Transcranial Magnetic Stimulation Indices of Cortical Excitability Enhance the Prediction of Response to Pharmacotherapy in Late-Life Depression.
Topics: Aged; Cortical Excitability; Depression; Humans; Inhibition, Psychological; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2022 |
Ghost Pills: A Case Report.
Topics: Aged; Antidepressive Agents, Second-Generation; Anxiety; Delayed-Action Preparations; Depression; Feces; Humans; Huntington Disease; Male; Venlafaxine Hydrochloride | 2017 |
Insight into the metabolic mechanism of Diterpene Ginkgolides on antidepressant effects for attenuating behavioural deficits compared with venlafaxine.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Diterpenes; Ginkgolides; Male; Metabolic Networks and Pathways; Metabolomics; Mice; Venlafaxine Hydrochloride | 2017 |
Activation of indoleamine 2, 3- dioxygenase pathway by olanzapine augments antidepressant effects of venlafaxine in mice.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depression; Depressive Disorder, Treatment-Resistant; Female; Hippocampus; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; Interleukin-1beta; Interleukin-6; Kynurenine; Male; Mice; Olanzapine; Serotonin; Stress, Psychological; Swimming; Tryptophan; Venlafaxine Hydrochloride | 2017 |
Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder.
Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Case-Control Studies; China; Cytokines; Depression; Depressive Disorder, Major; Female; Humans; Interleukin-1beta; Interleukin-6; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2018 |
Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats.
Topics: Acetamides; Animals; Antidepressive Agents, Second-Generation; Body Weight; Corticosterone; Depression; Feeding Behavior; Immobilization; Male; Memory Disorders; Organ Size; Physical Conditioning, Animal; Rats; Rats, Wistar; Running; Stress, Physiological; Venlafaxine Hydrochloride | 2017 |
Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters.
Topics: Adult; Biomarkers; Brain-Derived Neurotrophic Factor; Cross-Sectional Studies; Depression; Female; Humans; Longitudinal Studies; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2018 |
The influence of aripiprazole and venlafaxine on the antidepressant-like effect observed in prenatally stressed rats (animal model of depression).
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Depression; Disease Models, Animal; Drug Therapy, Combination; Female; Locomotion; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Stress, Psychological; Swimming; Venlafaxine Hydrochloride | 2018 |
Perinatal exposure to venlafaxine leads to lower anxiety and depression-like behavior in the adult rat offspring.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Animals, Newborn; Anxiety; Anxiety Disorders; Behavior, Animal; Brain; Corticosterone; Depression; Depressive Disorder; Female; Fluoxetine; Hippocampus; Male; Maternal Behavior; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Venlafaxine Hydrochloride | 2018 |
Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Depression; Fluoxetine; Ganglia, Spinal; Humans; Norepinephrine; Pineal Gland; Receptors, Nicotinic; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin; Smoking Cessation; Venlafaxine Hydrochloride | 2018 |
Antidepressants in breast milk; comparative analysis of excretion ratios.
Topics: Adult; Antidepressive Agents; Breast Feeding; Child Development; Citalopram; Depression; Female; Humans; Infant; Milk, Human; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2019 |
The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Citalopram; Cytochrome P450 Family 2; Depression; Gene Expression Regulation, Enzymologic; Male; Microsomes, Liver; Rats; Rats, Wistar; Stress, Physiological; Sucrose; Venlafaxine Hydrochloride | 2018 |
Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Imipramine; Ketamine; Male; Prefrontal Cortex; Rats; Rats, Inbred WKY; Rats, Wistar; Stress, Psychological; Venlafaxine Hydrochloride | 2019 |
Venlafaxine Mitigates Depressive-Like Behavior in Ovariectomized Rats by Activating the EPO/EPOR/JAK2 Signaling Pathway and Increasing the Serum Estradiol Level.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Depression; Erythropoietin; Estradiol; Female; Janus Kinase 2; Motor Activity; Ovariectomy; Rats; Rats, Wistar; Receptors, Erythropoietin; Signal Transduction; Venlafaxine Hydrochloride | 2019 |
Antidepressant mechanisms of venlafaxine involving increasing histone acetylation and modulating tyrosine hydroxylase and tryptophan hydroxylase expression in hippocampus of depressive rats.
Topics: Acetylation; Animals; Antidepressive Agents; Depression; Hippocampus; Histones; Male; Rats; Rats, Sprague-Dawley; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase; Venlafaxine Hydrochloride | 2019 |
Venlafaxine and nortriptyline reverse acute dexamethasone-induced depressive-like behaviors in male and female mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Dexamethasone; Female; Hypothalamo-Hypophyseal System; Male; Mice; Nortriptyline; Pituitary-Adrenal System; Venlafaxine Hydrochloride | 2019 |
The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression.
Topics: Animals; Behavior, Animal; Deep Brain Stimulation; Depression; Depressive Disorder, Treatment-Resistant; Dopamine; Dopamine Agonists; Dopamine Antagonists; Male; Memory Consolidation; Models, Animal; Prefrontal Cortex; Rats; Rats, Inbred WKY; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Venlafaxine Hydrochloride | 2019 |
Depression with high levels of anxiety.
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder, Major; Humans; Venlafaxine Hydrochloride | 2019 |
Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Circadian Rhythm; Depression; Dopamine; Fluoxetine; Imipramine; Male; Mice; Mice, Inbred C57BL; Movement; Norepinephrine; Time Factors; Venlafaxine Hydrochloride | 2019 |
Antidepressant effect of venlafaxine in chronic unpredictable stress: Evidence of the involvement of key enzymes responsible for monoamine neurotransmitter synthesis and metabolism.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Biogenic Monoamines; Depression; Hippocampus; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Monoamine Oxidase; Rats, Sprague-Dawley; Stress, Physiological; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase; Venlafaxine Hydrochloride | 2019 |
Psychomotor depressive symptoms may differentially respond to venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Prospective Studies; Psychomotor Agitation; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Cerebral Cortex; Cyclohexanols; Cyclopropanes; Depression; Dopamine; Duloxetine Hydrochloride; Humans; Male; Mice; Milnacipran; Motor Activity; Neurotransmitter Transport Proteins; Norepinephrine; Rats; Serotonin; Synaptosomes; Thiophenes; Venlafaxine Hydrochloride | 2013 |
The combined treatment of venlafaxine and quetiapine for treatment-resistant depression: a clinical study.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cohort Studies; Cyclohexanols; Depression; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Cyclohexanols; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Male; Maze Learning; Morpholines; Physical Conditioning, Animal; Rats; Rats, Wistar; Reboxetine; Restraint, Physical; Running; Stress, Psychological; Sucrose; Swimming; Venlafaxine Hydrochloride | 2013 |
Changes in the utilization of venlafaxine after the introduction of generics in Sweden.
Topics: Antidepressive Agents, Second-Generation; Confidence Intervals; Cyclohexanols; Depression; Drug Prescriptions; Drugs, Generic; Humans; Sweden; Venlafaxine Hydrochloride | 2013 |
Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
Topics: Abortion, Spontaneous; Adult; Antidepressive Agents; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Humans; Maternal-Fetal Exchange; Mianserin; Mirtazapine; Pregnancy; Risk; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2013 |
[Antidepressant treatment associated hyponatremia -- case report].
Topics: Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Critical Care; Cyclohexanols; Depression; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hyponatremia; Male; Mianserin; Mirtazapine; Recurrence; Severity of Illness Index; Sodium; Suicide, Attempted; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
When depression doesn't lead with depression.
Topics: Anger; Bipolar Disorder; Cyclohexanols; Depression; Depressive Disorder, Major; Emotions; Female; Fluoxetine; Humans; Irritable Mood; Male; Mood Disorders; Prefrontal Cortex; Venlafaxine Hydrochloride | 2013 |
Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression.
Topics: Administration, Intranasal; Alginates; Animals; Antidepressive Agents; Brain; Cyclohexanols; Depression; Disease Models, Animal; Female; Glucuronic Acid; Hexuronic Acids; Male; Motor Activity; Nanoparticles; Nasal Mucosa; Pharmacokinetics; Rats; Rats, Wistar; Swimming; Time Factors; Venlafaxine Hydrochloride | 2014 |
Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.
Topics: Adult; Aged; Antidepressive Agents; Biotransformation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Doxepin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; GABA Agents; Germany; Histamine Antagonists; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Venlafaxine Hydrochloride | 2014 |
Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
Topics: Aged; Antidepressive Agents; Anxiety; Cyclohexanols; Datasets as Topic; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Venlafaxine Hydrochloride | 2014 |
Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Apoptosis; Behavior, Animal; Blotting, Western; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Male; Microscopy, Electron, Transmission; Neurons; Rats; Rats, Sprague-Dawley; Up-Regulation; Venlafaxine Hydrochloride | 2014 |
Venlafaxine increases cell proliferation and regulates DISC1, PDE4B and NMDA receptor 2B expression in the hippocampus in chronic mild stress mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Depression; Hippocampus; Male; Mice; Motor Activity; Nerve Tissue Proteins; Receptors, N-Methyl-D-Aspartate; Stress, Psychological; Venlafaxine Hydrochloride | 2015 |
Differential co-expression and regulation analyses reveal different mechanisms underlying major depressive disorder and subsyndromal symptomatic depression.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Biomarkers; Case-Control Studies; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Gene Regulatory Networks; Humans; Leukocytes, Mononuclear; Male; Microarray Analysis; Venlafaxine Hydrochloride | 2015 |
[Venlafaxine in the treatment of moderate and severe depressions: the ways to increase treatment efficacy].
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.
Topics: Animals; Apoptosis; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Hippocampus; Male; Neurons; Nitric Oxide; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain | 2014 |
LC-MS/MS based studies on the anti-depressant effect of hypericin in the chronic unpredictable mild stress rat model.
Topics: Amino Acids; Animals; Anthracenes; Antidepressive Agents; Behavior, Animal; Chromatography, Liquid; Corticosterone; Depression; Disease Models, Animal; Male; Neurotransmitter Agents; Perylene; Rats; Stress, Psychological; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2015 |
Venlafaxine reverses decreased proliferation in the subventricular zone in a rat model of early life stress.
Topics: Animals; Behavior, Animal; Cell Proliferation; Cognition Disorders; Corticosterone; Depression; Lateral Ventricles; Male; Maternal Deprivation; Random Allocation; Rats; Receptors, Glucocorticoid; Stress, Psychological; Venlafaxine Hydrochloride | 2015 |
An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price Neutrality.
Topics: Antidepressive Agents, Second-Generation; Comparative Effectiveness Research; Cost Savings; Cost-Benefit Analysis; Databases, Pharmaceutical; Depression; Drug Costs; Drug Substitution; Drugs, Generic; Female; Humans; Male; Middle Aged; Models, Economic; New Zealand; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Depression; Drug Utilization Review; Duloxetine Hydrochloride; Female; Humans; Incidence; Insurance, Health; Male; Middle Aged; Propensity Score; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; United States; Venlafaxine Hydrochloride; Young Adult | 2015 |
Hyperostosis frontalis interna presenting as depression and parkinsonism in an older woman.
Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Female; Frontal Bone; Humans; Hyperostosis Frontalis Interna; Parkinsonian Disorders; Venlafaxine Hydrochloride | 2016 |
Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Depression; Drug Administration Schedule; Electronic Health Records; Female; Humans; Incidence; Male; Registries; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2015 |
Failure to thrive potentially secondary to maternal venlafaxine use.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Body Weight; Breast Feeding; Depression; Failure to Thrive; Female; Humans; Infant, Newborn; Pregnancy; Venlafaxine Hydrochloride | 2016 |
NMR-based metabonomic analysis of normal rat urine and faeces in response to (±)-venlafaxine treatment.
Topics: Animals; Antidepressive Agents; Brain; Depression; Desvenlafaxine Succinate; Feces; Female; Magnetic Resonance Imaging; Metabolomics; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Urine; Venlafaxine Hydrochloride | 2016 |
Augmentation of effect of venlafaxine by folic acid in behavioral paradigms of depression in mice: Evidence of serotonergic and pro-inflammatory cytokine pathways.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Depression; Depressive Disorder; Disease Models, Animal; Dopamine; Folic Acid; Hindlimb Suspension; Inflammation; Interleukin-1beta; Interleukin-6; Mice; Motor Activity; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Venlafaxine Hydrochloride | 2016 |
Coadministration of tramadol with aripiprazole and venlafaxine--The effect on spatial memory functions in male rats.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Chronic Pain; Depression; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Spatial Memory; Tramadol; Venlafaxine Hydrochloride | 2016 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
The Effects of Antidepressants and Quetiapine on Heart Rate Variability.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Depression; Female; Heart Rate; Humans; Linear Models; Male; Medically Unexplained Symptoms; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Sertraline; Taiwan; Venlafaxine Hydrochloride | 2016 |
Intrinsic functional connectivity in late-life depression: trajectories over the course of pharmacotherapy in remitters and non-remitters.
Topics: Aged; Aripiprazole; Brain; Brain Mapping; Depression; Depressive Disorder; Executive Function; Female; Frontal Lobe; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Parietal Lobe; Rest; Temporal Lobe; Venlafaxine Hydrochloride | 2017 |
Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway.
Topics: Acetamides; Animals; Antidepressive Agents; Depression; Drug Synergism; Female; Hindlimb Suspension; Hypnotics and Sedatives; Kynurenine; Male; Mice; Signal Transduction; Swimming; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism.
Topics: Antidepressive Agents, Second-Generation; Cardiotoxicity; Cytochrome P-450 CYP2D6; Depression; Drug Overdose; Female; Genotype; Humans; Middle Aged; Suicide, Attempted; Venlafaxine Hydrochloride | 2016 |
Ovariectomy changes the response to antidepressant drugs in tail suspension test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Doxepin; Estrogens; Female; Hindlimb Suspension; Menopause; Mice; Mice, Inbred ICR; Ovariectomy; Paroxetine; Venlafaxine Hydrochloride | 2016 |
Selective solid-phase extraction using molecularly imprinted polymers for analysis of venlafaxine, O-desmethylvenlafaxine, and N-desmethylvenlafaxine in plasma samples by liquid chromatography-tandem mass spectrometry.
Topics: Acrylates; Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Depression; Desvenlafaxine Succinate; Humans; Methacrylates; Microscopy, Electron, Scanning; Molecular Imprinting; Nitriles; Polymerization; Polymers; Solid Phase Extraction; Spectroscopy, Fourier Transform Infrared; Tandem Mass Spectrometry; Toluene; Venlafaxine Hydrochloride | 2016 |
GC-MS-based metabolomic study on the antidepressant-like effects of diterpene ginkgolides in mouse hippocampus.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Gas Chromatography-Mass Spectrometry; Ginkgo biloba; Ginkgolides; Hippocampus; Male; Metabolomics; Mice, Inbred C57BL; Motor Activity; Oxidative Stress; Plant Extracts; Venlafaxine Hydrochloride | 2016 |
Venlafaxine and takotsubo syndrome: Can we learn more from published patient cases?
Topics: Antidepressive Agents, Second-Generation; Depression; Electrocardiography; Female; Humans; Middle Aged; Serotonin and Noradrenaline Reuptake Inhibitors; Takotsubo Cardiomyopathy; Venlafaxine Hydrochloride | 2016 |
Venlafaxine ameliorates the depression-like behaviors and hippocampal S100B expression in a rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Body Weight; Depression; Disease Models, Animal; Gene Expression Regulation; Hippocampus; Male; Random Allocation; Rats; Rats, Sprague-Dawley; S100 Calcium Binding Protein beta Subunit; Stress, Psychological; Venlafaxine Hydrochloride | 2016 |
Opsoclonus-myoclonus ataxia syndrome secondary to venlafaxine intoxication.
Topics: Adult; Antidepressive Agents, Second-Generation; Ataxia; Depression; Female; Humans; Opsoclonus-Myoclonus Syndrome; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2017 |
[Rare delusional ideation of zoanthropy].
Topics: Amitriptyline; Antidepressive Agents; Delusions; Depression; Female; Humans; Middle Aged; Venlafaxine Hydrochloride | 2018 |
Do new-generation antidepressants work?
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Piperazines; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2008 |
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Mice; Receptors, Adrenergic, alpha-2; Risperidone; Swimming; Venlafaxine Hydrochloride; Yohimbine | 2008 |
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depression; Down-Regulation; Fenclonine; Male; Monoamine Oxidase Inhibitors; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Protein Synthesis Inhibitors; Protriptyline; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2009 |
Experience of the use of velaxin (venlafaxine) in anxious depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Female; Humans; Inpatients; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine.
Topics: Acculturation; Adult; Analgesics; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Culture; Cyclohexanols; Depression; Ethnicity; Europe; Europe, Eastern; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Physicians, Family; Psychophysiologic Disorders; Severity of Illness Index; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Base Sequence; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; DNA Mutational Analysis; Female; Gene Duplication; Genotype; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Sequence Deletion; Venlafaxine Hydrochloride | 2009 |
Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
Topics: Aged; Analgesics; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Manitoba; Retrospective Studies; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2009 |
Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Depression; Female; Humans; Middle Aged; Models, Chemical; Polymorphism, Genetic; Risk; Venlafaxine Hydrochloride | 2009 |
Fulminant hepatic failure induced by venlafaxine and trazodone therapy: a case report.
Topics: Aspartate Aminotransferases; Bilirubin; Cyclohexanols; Depression; Factor V; Female; Humans; International Normalized Ratio; Jaundice; Liver Failure, Acute; Liver Transplantation; Middle Aged; Selective Serotonin Reuptake Inhibitors; Trazodone; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Agomelatine: new drug. Adverse effects and no proven efficacy.
Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Involvement of potassium channels in the antidepressant-like effect of venlafaxine in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Male; Mice; Motor Activity; Potassium Channel Blockers; Potassium Channels; Venlafaxine Hydrochloride | 2010 |
Healthcare expenditure in severely depressed patients treated with escitalopram, generic SSRIs or venlafaxine in the UK.
Topics: Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depression; Drugs, Generic; Female; Health Care Costs; Humans; Male; Middle Aged; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; United Kingdom; Venlafaxine Hydrochloride; Young Adult | 2010 |
The venlafaxine "heart revenge:" a short report.
Topics: Adult; Antidepressive Agents, Second-Generation; Coronary Angiography; Creatine Kinase; Cyclohexanols; Depression; Drug Overdose; Electrocardiography; Fatal Outcome; Female; Humans; Myocardial Infarction; Oxygen; Suicide, Attempted; Troponin I; Venlafaxine Hydrochloride | 2010 |
Physician speciality and pain reduction in patients with depressive symptoms under treatment with venlafaxine.
Topics: Adult; Aged; Analgesics; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Perception; Physicians; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Overdose; Echocardiography; Female; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Takotsubo Cardiomyopathy; Venlafaxine Hydrochloride | 2010 |
Antidepressant-like effect of venlafaxine is abolished in μ-opioid receptor-knockout mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Opioid, mu; Swimming; Venlafaxine Hydrochloride | 2010 |
Association between antidepressant use during pregnancy and infants born small for gestational age.
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Canada; Case-Control Studies; Confounding Factors, Epidemiologic; Cyclohexanols; Depression; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Middle Aged; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Imipramine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nitric Oxide; Swimming; Venlafaxine Hydrochloride | 2011 |
Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Behavior, Animal; Biogenic Amines; Brain; Cyclohexanols; Depression; Disease Models, Animal; Hindlimb Suspension; Hypnotics and Sedatives; Isoquinolines; Male; Mice; Motor Activity; Neurotransmitter Agents; Pentobarbital; Reserpine; Sleep; Swimming; Venlafaxine Hydrochloride | 2011 |
Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium.
Topics: Animals; bcl-2-Associated X Protein; bcl-X Protein; Cyclohexanols; Depression; Gene Expression Regulation; Hippocampus; Male; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Hippocampal CA3 calcineurin activity participates in depressive-like behavior in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bridged Bicyclo Compounds; CA3 Region, Hippocampal; Calcineurin; Calcineurin Inhibitors; Cyclohexanols; Cyclosporine; Depression; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Body Weight; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Food Preferences; Gas Chromatography-Mass Spectrometry; Male; Metabolomics; Motor Activity; Principal Component Analysis; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
Effects of venlafaxine and escitalopram treatments on NMDA receptors in the rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Random Allocation; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Venlafaxine Hydrochloride | 2011 |
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.
Topics: Action Potentials; Animals; Antidepressive Agents, Second-Generation; Anxiety; Brain; Corticosterone; Cyclohexanols; Depression; Disease Models, Animal; Female; Hippocampus; Limbic System; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Imaging; Norepinephrine; Organic Cation Transport Proteins; Organic Cation Transporter 2; Radioligand Assay; Serotonin; Venlafaxine Hydrochloride | 2012 |
Venlafaxine protects against stress-induced oxidative DNA damage in hippocampus during antidepressant testing in mice.
Topics: Animals; Antidepressive Agents; Cyclohexanols; Depression; DNA Damage; Hippocampus; Male; Mice; Oxidative Stress; Random Allocation; Stress, Psychological; Venlafaxine Hydrochloride | 2011 |
[Approximate entropy of the placebo effect in clinical trials of newer antidepressants].
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depression; Fluoxetine; Humans; Paroxetine; Placebo Effect; Placebos; Severity of Illness Index; Venlafaxine Hydrochloride | 2010 |
[Effect of venlafaxine on cognitive function and hippocampal brain-derived neurotrophic factor expression in rats with post-stroke depression].
Topics: Animals; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Disease Models, Animal; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Rats; Rats, Sprague-Dawley; Stroke; Venlafaxine Hydrochloride | 2011 |
Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus.
Topics: Age Factors; Animals; Antidepressive Agents, Second-Generation; Corticosterone; Cyclohexanols; Depression; Excitatory Amino Acid Transporter 1; Female; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Hippocampus; Male; Maternal Deprivation; Nerve Net; Neurons; Rats; Venlafaxine Hydrochloride | 2012 |
The analysis of binary longitudinal data with time-dependent covariates.
Topics: Antidepressive Agents, Second-Generation; Computer Simulation; Cyclohexanols; Data Interpretation, Statistical; Depression; Humans; Likelihood Functions; Lithium; Logistic Models; Longitudinal Studies; Regression Analysis; Venlafaxine Hydrochloride | 2012 |
Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
Topics: Aged; Aged, 80 and over; Australia; Coronary Artery Bypass; Coronary Artery Disease; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Hospital Mortality; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Hemorrhage; Proportional Hazards Models; Renal Dialysis; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2012 |
Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Chemical Fractionation; Cyclohexanols; Depression; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Ethanol; Hippocampus; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase; Motor Activity; Norepinephrine; Phytotherapy; Plants, Medicinal; Prefrontal Cortex; Serotonin; Solvents; Time Factors; Venlafaxine Hydrochloride | 2012 |
Hypoglycaemia: a little known effect of Venlafaxine overdose.
Topics: Adult; Alprazolam; Analgesics; Anti-Anxiety Agents; Cyclohexanols; Depression; Drug Overdose; Drug Therapy, Combination; Female; Gastrointestinal Agents; Half-Life; Humans; Hypoglycemia; Octreotide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Treatment Outcome; Venlafaxine Hydrochloride | 2012 |
Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biomarkers; Chronic Disease; Cyclohexanols; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Fluoxetine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Motor Activity; Multivariate Analysis; Rats; Rats, Sprague-Dawley; Stress, Psychological; Sucrose; Venlafaxine Hydrochloride | 2012 |
Long-lasting effects of chronic rTMS to treat chronic rodent model of depression.
Topics: Adrenocorticotropic Hormone; Anhedonia; Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Blotting, Western; Body Weight; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cyclohexanols; Depression; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Food Preferences; Hydrocortisone; Male; MAP Kinase Signaling System; Motor Activity; Neurogenesis; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming; Transcranial Magnetic Stimulation; Venlafaxine Hydrochloride | 2012 |
Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Cyclohexanols; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Risk Factors; RNA, Messenger; Social Behavior; Stress, Psychological; Thiazepines; Venlafaxine Hydrochloride; Vesicular Glutamate Transport Protein 1 | 2012 |
Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.
Topics: Animals; Antidepressive Agents, Second-Generation; Calcineurin Inhibitors; Cyclohexanols; Cyclosporine; Depression; Disease Models, Animal; Immunosuppressive Agents; Male; Microinjections; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sucrose; Tacrolimus; TOR Serine-Threonine Kinases; Venlafaxine Hydrochloride | 2013 |
Plasma exchange in the management of a case of hypertriglyceridaemic pancreatitis triggered by venlafaxine.
Topics: Adult; Cyclohexanols; Depression; Diagnosis, Differential; Fluid Therapy; Humans; Hypertriglyceridemia; Male; Pancreatitis, Acute Necrotizing; Plasma Exchange; Selective Serotonin Reuptake Inhibitors; Tomography, X-Ray Computed; Venlafaxine Hydrochloride | 2012 |
Venlafaxine causing akathisia: a case report.
Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Humans; Male; Venlafaxine Hydrochloride | 2012 |
Venlafaxine augmentation with lithium leading to serotonin syndrome.
Topics: Aged; Cyclohexanols; Depression; Drug Synergism; Humans; Lithium Chloride; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2012 |
Venlafaxine and risk of upper gastrointestinal bleeding in elderly depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Gastrointestinal Hemorrhage; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2012 |
Differences in clinician understanding and management of early menopause after breast cancer.
Topics: Anxiety; Australia; Breast Neoplasms; Cross-Sectional Studies; Cyclohexanols; Depression; Endocrinology; Exercise; Female; Follicle Stimulating Hormone; General Practitioners; General Surgery; Gynecology; Hot Flashes; Humans; Life Style; Medical Oncology; Menopause, Premature; Practice Patterns, Physicians'; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2013 |
Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Biogenic Monoamines; Brain; Cyclohexanols; Depression; Disease Models, Animal; Male; Metabolomics; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2013 |
[Delirium during withdrawal of venlafaxine].
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Delirium; Depression; Drug Administration Schedule; Half-Life; Humans; Male; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2002 |
Interaction between ECT and venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Atenolol; Combined Modality Therapy; Cyclohexanols; Depression; Electroconvulsive Therapy; Fatal Outcome; Female; Humans; Hypertension; Venlafaxine Hydrochloride | 2002 |
Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
Topics: Age Factors; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depression; Diabetes Mellitus; Fee-for-Service Plans; Female; Health Status; Heart Diseases; Humans; Hypertension; Male; Medicare; Monoamine Oxidase Inhibitors; Multivariate Analysis; Racial Groups; Sample Size; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sex Factors; Socioeconomic Factors; Venlafaxine Hydrochloride | 2003 |
[Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Mania associated with venlafaxine discontinuation.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Cyclohexanols; Depression; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 2003 |
Risperidone-responsive segmental dystonia and pallidal deep brain stimulation.
Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depression; Dopamine Antagonists; Dystonic Disorders; Electric Stimulation Therapy; Globus Pallidus; Humans; Male; Parkinson Disease, Secondary; Risperidone; Severity of Illness Index; Venlafaxine Hydrochloride | 2003 |
Mirtazapine-induced hyponatraemia.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depression; Female; Humans; Hyponatremia; Mianserin; Mirtazapine; Venlafaxine Hydrochloride | 2003 |
Hypertensive crisis associated with venlafaxine.
Topics: Adult; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Disulfiram; Drug Interactions; Humans; Hypertension; Venlafaxine Hydrochloride | 2003 |
Venlafaxine-induced depression of wind-up activity in mononeuropathic rats is potentiated by inhibition of brain 5-HT1A receptor expression in vivo.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Synergism; Fever; Hyperalgesia; Infusion Pumps, Implantable; Male; Oligonucleotides, Antisense; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Reflex; Regression, Psychology; Sciatic Neuropathy; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Time Factors; Venlafaxine Hydrochloride | 2004 |
Massive venlafaxine overdose resulted in a false positive Abbott AxSYM urine immunoassay for phencyclidine.
Topics: Adolescent; Cyclohexanols; Depression; Drug Overdose; False Positive Reactions; Female; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Phencyclidine; Venlafaxine Hydrochloride | 2003 |
Is Effexor more effective for depression than an SSRI?
Topics: Cyclohexanols; Depression; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2004 |
Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Depression; Dibenzothiazepines; Drug Synergism; Drug Therapy, Combination; Female; Galactorrhea; Humans; Prolactin; Quetiapine Fumarate; Venlafaxine Hydrochloride | 2004 |
Spontaneous orgasm started with venlafaxine and continued with citalopram.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Citalopram; Combined Modality Therapy; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Orgasm; Patient Admission; Venlafaxine Hydrochloride | 2004 |
Bilateral acute angle closure caused by supraciliary effusions associated with venlafaxine intake.
Topics: Adult; Antidepressive Agents, Second-Generation; Antihypertensive Agents; Anxiety; Ciliary Body; Cyclohexanols; Depression; Glaucoma, Angle-Closure; Gonioscopy; Humans; Iris; Male; Microscopy, Acoustic; Ocular Hypertension; Venlafaxine Hydrochloride | 2005 |
Effects of extract of Ginkgo biloba with venlafaxine on brain injury in a rat model of depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain Injuries; Brain-Derived Neurotrophic Factor; Cyclohexanols; Depression; Drugs, Chinese Herbal; Ginkgo biloba; Hippocampus; Male; Phytotherapy; Rats; Rats, Wistar; Venlafaxine Hydrochloride | 2005 |
Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2005 |
Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the "neuro-immune" system.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Gene Expression Profiling; Humans; Lymphocytes; Male; Molecular Sequence Data; Neuroimmunomodulation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Venlafaxine Hydrochloride | 2005 |
Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Canada; Cyclohexanols; Depression; Direct Service Costs; Female; Health Expenditures; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
QT interval prolongation associated with venlafaxine administration.
Topics: Cyclohexanols; Depression; Electrocardiography; Female; Heart Conduction System; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine.
Topics: Animals; Antidepressive Agents, Second-Generation; Atmosphere Exposure Chambers; Behavior, Animal; Cyclohexanols; Depression; Female; Maze Learning; Memory; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Smoking; Swimming; Venlafaxine Hydrochloride | 2006 |
Dose-dependent Venlafaxine-induced sinus tachycardia.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Female; Humans; Tachycardia, Sinus; Venlafaxine Hydrochloride | 2006 |
High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma.
Topics: Antidepressive Agents, Second-Generation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Depression; Female; Humans; Male; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2007 |
Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Antioxidants; Brain; Cerebral Cortex; Cyclohexanols; Depression; Disease Models, Animal; Housing, Animal; Lipid Peroxidation; Male; Medulla Oblongata; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Venlafaxine Hydrochloride; Water Deprivation | 2007 |
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Carbazoles; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Ethylenediamines; Male; Mice; Motor Activity; Neuroprotective Agents; Pentazocine; Receptors, sigma; Sigma-1 Receptor; Swimming; Venlafaxine Hydrochloride | 2007 |
A case series of increased libido and spontaneous orgasm associated with venlafaxine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Libido; Orgasm; Venlafaxine Hydrochloride | 2008 |
[Velaxin (venlafaxine) in the treatment of anxious depression].
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depression; Female; Humans; Inpatients; Male; Middle Aged; Outpatients; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Venlafaxine marketed as antidepressant.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Humans; Selective Serotonin Reuptake Inhibitors; Tablets; Venlafaxine Hydrochloride | 1994 |
Hyponatremia with venlafaxine.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Female; Humans; Hyponatremia; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
[Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
Topics: Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Drug Administration Schedule; Humans; Hypertension; Nausea; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride | 1998 |
Venlafaxine withdrawal reactions.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride | 1998 |
Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Depression; Desipramine; Hippocampus; Injections, Intravenous; Iontophoresis; Male; Norepinephrine; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1998 |
Venlafaxine in the treatment of resistant postpsychotic depressive symptoms of schizophrenia.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Drug Resistance; Humans; Male; Middle Aged; Schizophrenia; Venlafaxine Hydrochloride | 1999 |
Diaphoresis and pruritus with extended-release venlafaxine.
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depression; Female; Humans; Pruritus; Sweating; Venlafaxine Hydrochloride | 1999 |
Antidepressant-induced bruxism successfully treated with gabapentin.
Topics: Acetates; Amines; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bruxism; Cyclohexanecarboxylic Acids; Cyclohexanols; Depression; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Venlafaxine Hydrochloride | 1999 |
Priapism associated with venlafaxine use.
Topics: Adolescent; Cyclohexanols; Depression; Humans; Male; Priapism; Recurrence; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Venlafaxine Hydrochloride | 2000 |
Venlafaxine and paroxetine in treatment-resistant depression.
Topics: Cyclohexanols; Depression; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Generalized anxiety disorder in family practice patients.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Depression; Diagnosis, Differential; Family Practice; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; United States; Venlafaxine Hydrochloride | 2000 |
Prefrontal changes and treatment response prediction in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride | 2001 |
The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Appetite; Body Weight; Brain; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Imipramine; Interleukin-1; Lipopolysaccharides; Male; Mice; Milk; Neuroimmunomodulation; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2001 |
Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome.
Topics: Adrenal Cortex Hormones; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Churg-Strauss Syndrome; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Paroxetine; Risperidone; Venlafaxine Hydrochloride | 2002 |
[Family physician's interventions and prescribing practice. Results of the GAD-P study].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Barbiturates; Behavior Therapy; Cyclohexanols; Depression; Female; Humans; Hypnotics and Sedatives; Male; Physicians, Family; Phytotherapy; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
An open-label, variable-dose study of WY-45,030 (venlafexine) in depressed outpatients.
Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Outpatients; Venlafaxine Hydrochloride | 1988 |